Fumaric Acid

Fumaric Acid

SCHEMBL4226822

COc1ccc(CNC(C(=O)NCc2ccc(Cl)cc2)c2ccccc2)cc1.O=C(O)/C=C/C(=O)O

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1ADRB2ATP4AATP4BAXLCHRM2CHRM3DRD2FLT3HRH1HTR2AHTR2BHTR2CKCNH2KMT2AMAP2K1MAP2K2MEN1MLNRPLK4RENS1PR1SLC6A2SLC6A4atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
KMT2A known ✓ Q03164 4/20 0.49
MEN1 known ✓ O00255 2/20 0.49
TDP1 Q9NUW8 1/20 0.58
CASR P41180 1/20 0.49
KLK7 P49862 1/20 0.48
KDM4E B2RXH2 1/20 0.47
ALDH1A1 P00352 3/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
ADRB3 P13945 1/20 0.47
NPC1 O15118 2/20 0.46
POLB P06746 1/20 0.46
RAB9A P51151 1/20 0.46
LMNA P02545 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL4226828 1.00 TDP1 (0.58) TDP1KMT2AMEN1CASRKLK7
Fumaric Acid SCHEMBL4220532 0.93 KMT2A (0.53) TDP1KMT2AMEN1CASRALDH1A1
Fumaric Acid SCHEMBL4220524 0.93 KMT2A (0.53) TDP1KMT2AMEN1CASRALDH1A1
Fumaric Acid SCHEMBL4233829 0.90 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2LMNA
Fumaric Acid SCHEMBL4233827 0.90 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2LMNA
Fumaric Acid SCHEMBL5108111 0.85 HRH1 (0.47) KMT2AMEN1POLBLMNA
Fumaric Acid SCHEMBL5108102 0.85 HRH1 (0.47) KMT2AMEN1POLBLMNA
SCHEMBL4237244 0.84 CYP1A2 (0.51) KMT2AMEN1ALDH1A1SMN1; SMN2LMNA
Fumaric Acid SCHEMBL4232774 0.83 SMN1; SMN2 (0.56) SMN1; SMN2
Fumaric Acid SCHEMBL4232765 0.83 SMN1; SMN2 (0.56) SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2096104-A1 Organic diamines as mGluR7 modulators Novartis AG (CH) 2009-09-02 EP disclosed
US-20080242698-A1 Organic Compounds NOVARTIS AG (CH) 2008-10-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080242698-A1 Organic Compounds AOC1, OTC, ODC1 KMT2A 1438/4885MEN1 464/4885TDP1 1575/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.